United States Biotechnology & Medical Research

Avenue Therapeutics Inc (ATXI)

Track

Ticker: ATXI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Avenue Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Sale 2 Dec 2024
Value US$977,058.31 | Price 405.80 | Shares 15,116 (-41.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-03 2024-12-02 S Sale
1.8
Herskowitz Neil
Non-Executive Director
15,116 -41.1%
405.80
US$977,058 		15,116 -41.1% 405.80 US$977,058
2024-11-07 2024-11-05 S Sale
1.2
KRANZLER JAY D
Non-Executive Director
80,631 +4.6%
99.62
US$1,437,859 		80,631 +4.6% 99.62 US$1,437,859
2024-10-01 2024-09-30 B Purchase
1.2
KRANZLER JAY D
Non-Executive Director
45,971 +22.5%
160.74
US$700,275 		45,971 +22.5% 160.74 US$700,275
2024-10-01 2024-09-27 B Purchase
1.2
KRANZLER JAY D
Non-Executive Director
3 +2.5%
2.40
US$7 		3 +2.5% 2.40 US$7
2023-12-13 2023-12-11 S Sale
0.8
Davidow Robert L
Large shareholder
20,000 -20.0%
0.14
US$2,800 		20,000 -20.0% 0.14 US$2,800
2023-12-13 2023-12-11 S Sale
0.8
Davidow Robert L
Large shareholder
128,000 -46.5%
0.14
US$17,920 		128,000 -46.5% 0.14 US$17,920
2023-12-13 2023-12-11 S Sale
0.8
Davidow Robert L
Large shareholder
126,000 -36.9%
0.14
US$17,640 		126,000 -36.9% 0.14 US$17,640
2023-12-13 2023-12-11 S Sale
0.8
Davidow Robert L
Large shareholder
61,000 -45.2%
0.14
US$8,540 		61,000 -45.2% 0.14 US$8,540
2023-12-13 2023-12-11 S Sale
0.8
Davidow Robert L
Large shareholder
18,000 -45.0%
0.15
US$2,700 		18,000 -45.0% 0.15 US$2,700
2023-12-13 2023-12-11 S Sale
0.8
Davidow Robert L
Large shareholder
264,000 -27.9%
0.14
US$36,960 		264,000 -27.9% 0.14 US$36,960
2023-09-12 2023-09-08 B Purchase
0.5
Fortress Biotech, Inc.
Large shareholder
418,410 +68.1%
0.72
US$301,255 		418,410 +68.1% 0.72 US$301,255
2023-09-12 2023-09-08 B Purchase
3.9
ROSENWALD LINDSAY A MD
Non-Executive Director
348,675 +6178.9%
0.72
US$251,046 		348,675 +6178.9% 0.72 US$251,046
2022-10-13 2022-10-11 S Sale
InvaGen Pharmaceuticals, Inc.
Large shareholder
388,888 -100.0%
7.71
US$2,999,882 		388,888 -100.0% 7.71 US$2,999,882
2021-05-07 2021-05-06 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
2,500 +1.9%
3.99
US$9,975 		2,500 +1.9% 3.99 US$9,975
2020-08-21 2020-08-20 S Sale
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
3,840 -6.3%
12.13
US$46,579 		3,840 -6.3% 12.13 US$46,579
2020-03-10 2020-03-10 B Purchase
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
1,889 +3.2%
7.94
US$14,999 		1,889 +3.2% 7.94 US$14,999
2020-03-10 2020-03-09 B Purchase
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
100 +0.2%
7.97
US$797 		100 +0.2% 7.97 US$797
2020-03-10 2020-03-09 B Purchase
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
1,400 +2.4%
7.99
US$11,186 		1,400 +2.4% 7.99 US$11,186
2020-03-02 2020-02-27 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
2,400 +2.0%
8.20
US$19,680 		2,400 +2.0% 8.20 US$19,680
2020-03-02 2020-02-26 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
161 +0.1%
8.73
US$1,406 		161 +0.1% 8.73 US$1,406
2020-02-25 2020-02-25 B Purchase
3.6
Vazzano Joseph Walter

Chief Financial Officer

Officer
1,200 +2.1%
9.09
US$10,908 		1,200 +2.1% 9.09 US$10,908
2020-02-25 2020-02-25 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
10,000 +9.1%
9.31
US$93,100 		10,000 +9.1% 9.31 US$93,100
2019-09-16 2019-09-12 B Purchase
2.3
Ingram Elizabeth Garrett
16,000 +inf%
6.27
US$100,320 		16,000 +inf% 6.27 US$100,320
2019-08-12 2019-08-09 S Sale Vazzano Joseph Walter

Chief Financial Officer

Officer
2,375 -4.0%
5.56
US$13,205 		2,375 -4.0% 5.56 US$13,205
2019-08-12 2019-08-08 S Sale Vazzano Joseph Walter

Chief Financial Officer

Officer
2,313 -3.8%
5.62
US$12,999 		2,313 -3.8% 5.62 US$12,999
2019-06-19 2019-06-18 B Purchase
1.8
Herskowitz Neil
2,000 +2.0%
5.83
US$11,660 		2,000 +2.0% 5.83 US$11,660
2019-06-19 2019-06-17 B Purchase
1.8
Herskowitz Neil
3,000 +3.2%
5.88
US$17,640 		3,000 +3.2% 5.88 US$17,640
2019-04-15 2019-04-15 B Purchase
1.8
Herskowitz Neil
1,000 +1.1%
4.52
US$4,520 		1,000 +1.1% 4.52 US$4,520
2019-03-29 2019-03-29 B Purchase
1.8
Herskowitz Neil
1,400 +1.5%
5.11
US$7,154 		1,400 +1.5% 5.11 US$7,154
2019-03-29 2019-03-28 B Purchase
1.8
Herskowitz Neil
600 +0.7%
5.11
US$3,066 		600 +0.7% 5.11 US$3,066
2019-02-25 2019-02-25 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
5,000 +5.8%
5.46
US$27,300 		5,000 +5.8% 5.46 US$27,300
2019-02-06 2019-02-05 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
1,850 +2.2%
5.77
US$10,674 		1,850 +2.2% 5.77 US$10,674
2019-02-06 2019-02-04 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
7,000 +9.0%
5.91
US$41,370 		7,000 +9.0% 5.91 US$41,370
2019-02-01 2019-01-30 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
650 +0.8%
5.91
US$3,842 		650 +0.8% 5.91 US$3,842
2019-01-30 2019-01-29 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
8,553 +12.5%
5.91
US$50,548 		8,553 +12.5% 5.91 US$50,548
2019-01-30 2019-01-28 B Purchase
1.8
Herskowitz Neil
Non-Executive Director
1,447 +2.2%
5.84
US$8,450 		1,447 +2.2% 5.84 US$8,450
2018-12-12 2018-12-10 B Purchase Paley Jeffrey Non-Executive Director
5,000 +6.7%
4.76
US$23,800 		5,000 +6.7% 4.76 US$23,800
2018-12-12 2018-12-03 B Purchase Paley Jeffrey Non-Executive Director
10,000 +15.5%
5.48
US$54,754 		10,000 +15.5% 5.48 US$54,754
2018-06-11 2018-06-08 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
5,234 +26.2%
4.34
US$22,716 		5,234 +26.2% 4.34 US$22,716
2018-04-25 2018-04-25 B Purchase Herskowitz Neil
1,000 +1.9%
3.80
US$3,800 		1,000 +1.9% 3.80 US$3,800
2017-10-18 2017-10-17 B Purchase Herskowitz Neil
1,000 +2.0%
5.01
US$5,010 		1,000 +2.0% 5.01 US$5,010
2017-10-10 2017-10-09 B Purchase Herskowitz Neil Non-Executive Director
500 +1.0%
5.24
US$2,620 		500 +1.0% 5.24 US$2,620
2017-10-10 2017-10-09 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
1,350 +7.2%
5.40
US$7,290 		1,350 +7.2% 5.40 US$7,290
2017-10-10 2017-10-06 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
2,900 +18.4%
5.63
US$16,327 		2,900 +18.4% 5.63 US$16,327
2017-10-10 2017-10-05 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
3,550 +29.1%
5.60
US$19,880 		3,550 +29.1% 5.60 US$19,880
2017-10-10 2017-10-04 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director
2,200 +22.0%
5.60
US$12,320 		2,200 +22.0% 5.60 US$12,320
Explore more

More insider trading research around Avenue Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America